119 related articles for article (PubMed ID: 9679532)
1. Beta-lactam antibiotics.
Holbrook KA; Lowy FD
Cancer Invest; 1998; 16(6):405-12. PubMed ID: 9679532
[No Abstract] [Full Text] [Related]
2. Part II. Introduction to the beta-lactam antibiotics.
Cooper TW; Gibbs WJ; Bronze MS; Greenfield RA
J Okla State Med Assoc; 2006 Oct; 99(10):516-20. PubMed ID: 17125105
[No Abstract] [Full Text] [Related]
3. [Pseudomonas aeruginosa and beta-lactam antibiotics at the time of Europe].
Cavallo JD; Mérens A
Pathol Biol (Paris); 2008; 56(7-8):435-8. PubMed ID: 19019568
[TBL] [Abstract][Full Text] [Related]
4. [Biological evaluation of the effect of beta-lactam antibiotics on apoptosis in human lymphoid cells in vitro].
Reshetnikov SI; Shchiglenko NA; Aliautdin RN
Eksp Klin Farmakol; 2001; 64(4):68-72. PubMed ID: 11589116
[TBL] [Abstract][Full Text] [Related]
5. [beta-Lactam antibiotics].
Marín M; Gudiol F
Enferm Infecc Microbiol Clin; 2003 Jan; 21(1):42-55. PubMed ID: 12550043
[TBL] [Abstract][Full Text] [Related]
6. In-vitro development of resistance to beta-lactam antibiotics in Streptococcus pneumoniae.
Carsenti-Etesse H; Durant J; De Salvador F; Bensoussan M; Bensoussan F; Pradier C; Thabaut A; Dellamonica P
J Antimicrob Chemother; 1995 Aug; 36(2):417-23. PubMed ID: 8522472
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a new metallo-beta-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes.
Perilli M; Caporale B; Celenza G; Pellegrini C; Docquier JD; Mezzatesta M; Rossolini GM; Stefani S; Amicosante G
Antimicrob Agents Chemother; 2007 Aug; 51(8):2988-90. PubMed ID: 17470648
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium abscessus l,d-Transpeptidases Are Susceptible to Inactivation by Carbapenems and Cephalosporins but Not Penicillins.
Kumar P; Chauhan V; Silva JRA; Lameira J; d'Andrea FB; Li SG; Ginell SL; Freundlich JS; Alves CN; Bailey S; Cohen KA; Lamichhane G
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760902
[TBL] [Abstract][Full Text] [Related]
9. Third-generation cephalosporin and carbapenem resistance in Streptococcus mitis/oralis. Results from a nationwide registry in the Netherlands.
van Prehn J; van Triest MI; Altorf-van der Kuil W; van Dijk K;
Clin Microbiol Infect; 2019 Apr; 25(4):518-520. PubMed ID: 30528371
[No Abstract] [Full Text] [Related]
10. Regulation of beta-lactamase induction in gram-negative bacteria: a key to understanding the resistance puzzle.
Niemeyer DM
Mil Med; 1994 Dec; 159(12):732-5. PubMed ID: 7723996
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial therapy: problems and promises, Part I.
Neu HC
Hosp Pract (Off Ed); 1990 May; 25(5):63-74, 77-8. PubMed ID: 2110176
[TBL] [Abstract][Full Text] [Related]
12. Continuous infusion of beta-lactam antibiotics.
MacGowan AP; Bowker KE
Clin Pharmacokinet; 1998 Nov; 35(5):391-402. PubMed ID: 9839090
[TBL] [Abstract][Full Text] [Related]
13. Targeting metallo-β-lactamase enzymes in antibiotic resistance.
King DT; Strynadka NC
Future Med Chem; 2013 Jul; 5(11):1243-63. PubMed ID: 23859206
[TBL] [Abstract][Full Text] [Related]
14. Excretion of beta-lactam antibiotics in sweat--a neglected mechanism for development of antibiotic resistance?
Hoiby N; Pers C; Johansen HK; Hansen H
Antimicrob Agents Chemother; 2000 Oct; 44(10):2855-7. PubMed ID: 10991872
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993.
Chen HY; Yuan M; Livermore DM
J Med Microbiol; 1995 Oct; 43(4):300-9. PubMed ID: 7562993
[TBL] [Abstract][Full Text] [Related]
16. Molecular docking and molecular dynamics studies on β-lactamases and penicillin binding proteins.
Kumar KM; Anbarasu A; Ramaiah S
Mol Biosyst; 2014 Apr; 10(4):891-900. PubMed ID: 24503740
[TBL] [Abstract][Full Text] [Related]
17. [Antibiotics: from the way it works to antibacterial therapy part I (of IV)].
Melchior M; van Hout-van Dijk J
Tijdschr Diergeneeskd; 2011 Jul; 136(7):494-9. PubMed ID: 21870574
[No Abstract] [Full Text] [Related]
18. In-vitro activity of azlocillin and other beta-lactam antibiotics against enterococci.
Grimm H
J Antimicrob Chemother; 1983 May; 11 Suppl B():43-9. PubMed ID: 6413483
[TBL] [Abstract][Full Text] [Related]
19. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
20. Use of Michaelis-Menten kinetics in the analysis of synergism between beta-lactam antibiotics.
Hamilton-miller JM
J Theor Biol; 1971 May; 31(2):171-6. PubMed ID: 5208138
[No Abstract] [Full Text] [Related]
[Next] [New Search]
